This work is licensed under a Creative Commons Attribution 4.0 International License.
SEQ ID NO: 482 of Patent CN110785183A
General Information
DRACP ID DRACP06765
Peptide Name SEQ ID NO: 482 of Patent CN110785183A
Sequence TEREWADEW
Sequence Length 9
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Cancer targeted peptides Immunotherapeutic peptides
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target HLA-B*44
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C54H72N14O19
Absent amino acids CFGHIKLMNPQSVY
Common amino acids E
Mass 136412
Pl 3.78
Basic residues 1
Acidic residues 4
Hydrophobic residues 3
Net charge -3
Boman Index -4017
Hydrophobicity -213.33
Aliphatic Index 11.11
Half Life
Mammalian: 1 hour
Yeast: 2 min
E.coli: 2 min
Extinction Coefficient cystines 11000
Absorbance 280nm 1375
Polar residues 1
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID CN110785183A
Patent Title Novel Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including Nsclc, Sclc and Other Cancers
Other Iinformation Not available
Other Published ID Not available
This work is licensed under a Creative Commons Attribution 4.0 International License.